The CEPHIA project is launched

As of January 2011, the Bill & Melinda Gates Foundation funded initiative to characterize incidence assays is formally live. CEPHIA (the Consortium for the Evaluation and Performance of HIV Incidence Assays) aims to evaluate and compare currently available assays for the detection of recent HIV infection, using a common set of well-characterised specimens collected for this purpose; and to assess the suitability of the assays, alone or in combination, for accurate HIV incidence estimation in populations.